Oncomine Myelodysplastic Syndrome MDS Panel Test
Introduction to the Oncomine MDS Panel Test
The Oncomine Myelodysplastic Syndrome (MDS) Panel Test is a state-of-the-art molecular diagnostic tool utilized in the detection and analysis of genetic mutations associated with myelodysplastic syndromes and various types of leukemia. This test is essential for hematologists and oncologists in diagnosing and formulating treatment plans for patients exhibiting symptoms or risk factors related to these conditions.
What the Test Measures
This comprehensive test evaluates a panel of critical genes, including ASXL1, BCOR, CBL, DNMT3A, EZH2, FLT3, IDH1, IDH2, JAK2, KRAS, TP53, and several others, to detect mutations that may indicate the presence of myelodysplastic syndromes or leukemia. Additionally, it identifies fusion genes such as ETV6, JAK2, and RUNX1, which are significant in the context of hematological malignancies.
Who Should Consider This Test?
Patients who should consider the Oncomine MDS Panel Test include those:
- Experiencing symptoms such as unexplained fatigue, frequent infections, or easy bruising.
- With a family history of hematological disorders.
- Undergoing treatment for suspected myelodysplastic syndromes or leukemia.
- Requiring genetic counseling for informed decision-making regarding their health.
Benefits of Taking the Test
The Oncomine MDS Panel Test offers numerous benefits, including:
- Accurate detection of genetic mutations, aiding in early diagnosis.
- Informing personalized treatment strategies based on the specific genetic profile.
- Providing insights into prognosis and potential response to therapies.
- Facilitating genetic counseling for patients and their families.
Understanding Your Results
Results from the Oncomine MDS Panel Test are interpreted by qualified hematologists and oncologists. The presence of specific mutations or fusion genes will guide the treatment approach and management of the patient’s condition. It is crucial to discuss your results with your healthcare provider to understand their implications fully.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| Oncomine Myelodysplastic Syndrome MDS Panel Test | 819,000 | 910,000 |
How to Book the Test
To book the Oncomine Myelodysplastic Syndrome MDS Panel Test, please contact us at DNA Labs Nigeria. You can reach us via phone or WhatsApp at +2348110567037. Ensure you have a duly filled NGS Test Requisition Form (Form 40) ready for submission, as it is mandatory for processing your test.
Take charge of your health today with the Oncomine MDS Panel Test. Early detection can make a significant difference in treatment outcomes!
